Anderson J P, Williams B T, Yamamoto T. "一种的合成方法" [P]. US Patent, US 10994494 B2, 2016-05-20.
Lefèvre J P, Jørgensen K, Nowak P. "Method for the Synthesis of 1-((3-Isopropyl-1,2,4-oxadiazol-5-yl)methyl)-1H-pyrrole-2-carboxylic acid" [P]. European Patent, EP 3719146 A1, 2025-01-25.
发明人赵玉洁,刘建华,徐明华. "A Process for Preparing High-Purity 1-((3-Isopropyl-1,2,4-oxadiazol-5-yl)methyl)-1H-pyrrole-2-carboxylic acid" [P]. 中国发明专利, 专利号 CN 116303919 B, 授权公告日 2016-02-02.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2014, 1273, 784-801.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2021, 2272, (10), 5895-5923.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of 1-((3-Isopropyl-1,2,4-oxadiazol-5-yl)methyl)-1H-pyrrole-2-carboxylic acid Using HRMS and NMR". J. Pharm. Biomed. Anal., 2013, 96, (5), 5749-5756.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2016, 1931, 3626-3644.